EUVIMEDEUVIMED entdecken
Open Access

PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway

Lei Luo, Fengju Guan, Zhankun Wang, Bin Li, Xuemei Ding, Leilei Song, Lijiang Sun

Oncology Research · 2026 · 34 (7) · 1-10

DOI: 10.32604/or.2026.080621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Lei Luo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Urological Department, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Shinan District, Qingdao, China. Hauptthemen laut MEDLINE: Sunitinib, Drug Resistance, Neoplasm, Carcinoma, Renal Cell, STAT1 Transcription Factor. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SunitinibDrug Resistance, NeoplasmCarcinoma, Renal CellSTAT1 Transcription FactorKidney NeoplasmsInterferon Regulatory Factor-1Poly(ADP-ribose) PolymerasesHumansSignal TransductionCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticPiperazinesPhthalazines

Stichwörter der Autor:innen

Clear cell renal cell carcinomaISG15PARP9STAT1/IRF1 signaling pathwaysunitinib resistance

Substanzen

SunitinibSTAT1 Transcription FactorSTAT1 protein, humanInterferon Regulatory Factor-1Poly(ADP-ribose) PolymerasesIRF1 protein, humanolaparibPiperazinesPhthalazines

Autor:innen und Institutionen

  • Urological Department, The Affiliated Hospital of Qingdao University, No. 16, Jiangsu Road, Shinan District, Qingdao, China.
  • Urological Department, Qingdao Eighth People's Hospital, No. 84, Fengshan Road, Licang District, Qingdao, China.

Zitieren

APA

Luo, L., Guan, F., Wang, Z., Li, B., Ding, X., Song, L., & Sun, L. (2026). PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway. Oncology Research, 34(7), 1-10. https://doi.org/10.32604/or.2026.080621

Vancouver

Luo L, Guan F, Wang Z, Li B, Ding X, Song L, et al. PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway. Oncology Research. 2026;34(7):1-10. doi:10.32604/or.2026.080621

BibTeX
@article{Luo2026,
  author = {Luo, Lei and Guan, Fengju and Wang, Zhankun and Li, Bin and Ding, Xuemei and Song, Leilei and Sun, Lijiang},
  title = {PARP9 Modulates Sunitinib Resistance in Clear Cell Renal Cell Carcinoma via STAT1/IRF1 Signaling Pathway},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {7},
  pages = {1--10},
  doi = {10.32604/or.2026.080621}
}
Kostenlos starten →